
Quester Capital
Description
Quester Capital, operating as Questor Global Capital Partners Ltd, is a Kuala Lumpur-based principal investment firm with a significant focus on venture capital and private equity opportunities across Southeast Asia. While the firm's stated interest includes early-stage companies, its robust portfolio predominantly showcases investments in growth-stage enterprises, typically from Series B rounds onwards. Questor Capital strategically deploys capital into high-growth sectors such as fintech, e-commerce, digital services, and health tech, aiming to support companies with proven business models and significant market traction.
The firm acts as a key provider of growth capital, often participating in large, syndicated funding rounds alongside other prominent investors. Their investment thesis centers on identifying and backing leading technology companies poised for regional expansion and market leadership. Notable companies within their portfolio include regional giants like Xendit, ShopBack, Carsome, and Funding Societies, demonstrating their commitment to impactful investments in the digital economy.
Questor Capital's approach as a principal investment firm allows for flexibility in their capital deployment, enabling them to make substantial commitments to their portfolio companies. While specific check sizes can vary based on the stage and needs of the company, Questor typically provides first cheques ranging from approximately $2,000,000 to $15,000,000. This range reflects their participation in significant growth rounds, where they seek to acquire meaningful equity stakes. Their involvement often extends beyond capital, leveraging their network and expertise to support portfolio companies through their scaling journeys across Southeast Asia. The firm's consistent participation in multi-million and even multi-hundred-million dollar rounds underscores their capacity and strategic intent to fuel the growth of established regional players.
Investor Profile
Quester Capital has backed more than 24 startups, with 0 new investments in the last 12 months alone. The firm has led 5 rounds, about 21% of its total and boasts 10 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series B, Series C rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States.
- Strong thematic focus on Software, Biotechnology, Health Care.
- Typical check size: $2M – $15M.
Stage Focus
- Series Unknown (38%)
- Series B (29%)
- Series C (17%)
- Series A (17%)
Country Focus
- United Kingdom (96%)
- United States (4%)
Industry Focus
- Software
- Biotechnology
- Health Care
- Enterprise Software
- Health Diagnostics
- Database
- Hardware
- Medical
- Medical Device
- Security
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.